Screener
Aurinia Pharmaceuticals AUPH Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Commitments and contingencies (Note 5) | ||
| Shareholders' equity | ||
| Common shares — no par value, Unlimited shares authorized, 132,907 and 132,323 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | 1,117,248 | 1,120,035 |
| Additional paid-in capital | 76,192 | 111,263 |
| Accumulated other comprehensive loss | (977) | (599) |
| Accumulated deficit | (577,599) | (649,368) |
| Total shareholders' equity | 614,864 | 581,331 |
| Total liabilities and shareholders' equity | $792,262 | $751,587 |
Item 1. Financial Statements.
FAQ
- What is Aurinia Pharmaceuticals's total liabilities & equity?
- Aurinia Pharmaceuticals (AUPH) reported total liabilities & equity of $792.26M in Q2 2026.
- How has Aurinia Pharmaceuticals's total liabilities & equity changed year-over-year?
- Aurinia Pharmaceuticals's total liabilities & equity increased by 57.6% year-over-year, from $502.56M to $792.26M.
- What is the long-term trend for Aurinia Pharmaceuticals's total liabilities & equity?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's total liabilities & equity has grown at a 10.1% compound annual growth rate (CAGR), from $463.66M to $751.59M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Aurinia Pharmaceuticals's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude